Kevin Schuyler insider trades
Open-market stock purchases and sales by Kevin Schuyler, Director at Adial Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 31, 2018.
Open-market stock purchases and sales by Kevin Schuyler, Director at Adial Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 31, 2018.